(4-(2-(1,4-Dioxa-8-azaspiro[4.5]decan-8- yl)ethoxy)-3-fluorophenyl)boronic acid
98%
- Product Code: 89229
CAS:
1704082-85-8
| Molecular Weight: | 325.14 g./mol | Molecular Formula: | C₁₅H₂₁BFNO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
This chemical is primarily utilized in organic synthesis, particularly in the formation of carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions. Its boronic acid group enables it to act as a key intermediate in the production of complex organic molecules, including pharmaceuticals and agrochemicals. The presence of the fluorophenyl moiety enhances its reactivity and selectivity in these reactions, making it valuable for constructing biologically active compounds. Additionally, the dioxa-azaspirodecane structure contributes to its stability and solubility, facilitating its use in various catalytic processes. It is often employed in research and development settings to explore new drug candidates or optimize existing therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.500 | 10-20 days | $1,757.92 |
+
-
|
(4-(2-(1,4-Dioxa-8-azaspiro[4.5]decan-8- yl)ethoxy)-3-fluorophenyl)boronic acid
This chemical is primarily utilized in organic synthesis, particularly in the formation of carbon-carbon bonds through Suzuki-Miyaura cross-coupling reactions. Its boronic acid group enables it to act as a key intermediate in the production of complex organic molecules, including pharmaceuticals and agrochemicals. The presence of the fluorophenyl moiety enhances its reactivity and selectivity in these reactions, making it valuable for constructing biologically active compounds. Additionally, the dioxa-azaspirodecane structure contributes to its stability and solubility, facilitating its use in various catalytic processes. It is often employed in research and development settings to explore new drug candidates or optimize existing therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :